Effects of Concomitant Methotrexate on Large Joint Replacement in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors: A Multicenter Retrospective Cohort Study in Japan

Asai Shuji; Kojima Toshihisa; Oguchi Takeshi; Kaneko Atsushi; Hirano Yuji; Yabe Yuichiro; Kanayama Yasuhide; Takahashi Nobunori; Funahashi Koji; Hanabayashi Masahiro; Hirabara Shinya; Yoshioka Yutaka; Takemoto Toki; Terabe Kenya; Asai Nobuyuki; Ishiguro Naoki

首页> 外文期刊>Arthritis care & research >Effects of Concomitant Methotrexate on Large Joint Replacement in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors: A Multicenter Retrospective Cohort Study in Japan

【24h】

Effects of Concomitant Methotrexate on Large Joint Replacement in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors: A Multicenter Retrospective Cohort Study in Japan

机译：甲氨蝶呤对肿瘤坏死因子抑制剂治疗的类风湿关节炎患者大关节置换的影响：日本多中心回顾性队列研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective. To determine the effects of concomitant methotrexate (MTX) on the incidence of large joint replacement resulting from the progression of large joint destruction in patients with rheumatoid arthritis (RA) treated with tumor necrosis factor (TNF) inhibitors.

机译：目的。为了确定甲氨蝶呤（MTX）对大面积关节破坏发生率的大关节置换发生率的影响，该类风湿关节炎患者经肿瘤坏死因子（TNF）抑制剂治疗。

著录项

来源
《Arthritis care & research》 |2015年第10期|共8页
作者
Asai Shuji; Kojima Toshihisa; Oguchi Takeshi; Kaneko Atsushi; Hirano Yuji; Yabe Yuichiro; Kanayama Yasuhide; Takahashi Nobunori; Funahashi Koji; Hanabayashi Masahiro; Hirabara Shinya; Yoshioka Yutaka; Takemoto Toki; Terabe Kenya; Asai Nobuyuki; Ishiguro Naoki;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Effects of Concomitant Methotrexate on Large Joint Replacement in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors: A Multicenter Retrospective Cohort Study in Japan [J] . Asai Shuji, Kojima Toshihisa, Oguchi Takeshi, Arthritis care & research . 2015,第10期

机译：甲氨蝶呤对肿瘤坏死因子抑制剂治疗的类风湿关节炎患者大关节置换的影响：日本多中心回顾性队列研究
2. Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety. [J] . Komano Y, Tanaka M, Nanki T, The Journal of rheumatology . 2011,第7期

机译：用肿瘤坏死因子抑制剂治疗的类风湿关节炎患者严重感染的发生率和危险因素：日本类风湿关节炎患者长期安全登记处的报告。
3. Erratum: Golimumab, a human anti-tumor necrosis factor monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis [J] . li id=au1Paul Emery li id=au2Roy M. Fleischmann li id=au3Larry W. Moreland li id=au4Elizabeth C. Hsia li id=au5Ingrid Strusberg li id=au6Patrick Durez li id=au7Peter Nash li id=au8Eric Jason B. Amante li id=au9Melvin Churchill li id=au10Won Park li id=au11Bernardo Antonio Pons-Estel li id=au12Mittie K. Doyle li id=au13Sudha Visvanathan li id=au14Weichun Xu li id=au15Mahboob U. Rahman Arthritis & Rheumatism . 2010,第9期

机译：勘误：Golimumab，一种人类抗肿瘤坏死因子单克隆抗体，每隔四周皮下注射一次未接受甲氨蝶呤的活动性类风湿性关节炎患者：三期，多中心，随机，双盲，安慰剂治疗二十三周的结果氨甲蝶呤前戈利木单抗作为早期治疗类风湿关节炎的一线治疗的对照研究
4. A Multicenter Prospective Cohort Study of Tonsillectomy and Steroid Therapy in Japanese Patients with IgA Nephropathy: A 5-Year Report [C] . Mariko Miyazaki, Osamu Hotta, Atsushi Komatsud International Symposium on IgA Nephropathy . 2007

机译：日本IGA肾病患者扁桃体切除术和类固醇治疗的多中心前瞻性队列研究：5年报告
5. Predictors of Infection in Rheumatoid Arthritis Patients Using Anti-Tumor Necrosis Factor Agents [D] . Liu, Tasia 2017

机译：类风湿关节炎患者使用抗肿瘤坏死因子药物的感染预测因子
6. Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study [O] . José Inciarte-Mundo, Julio Ramirez, Maria Victoria Hernández, 2018

机译：钙卫蛋白强烈独立地预测类风湿关节炎和多关节银屑病关节炎患者接受肿瘤坏死因子抑制剂治疗的复发：一项为期一年的前瞻性队列研究
7. Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis : twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis. [O] . Emery, Paul, Fleischmann, Roy M, Moreland, Larry W, 2009

机译：Golimumab是一种人类抗肿瘤坏死因子α单克隆抗体，每4周一次向未接受甲氨蝶呤治疗的活动性类风湿关节炎患者皮下注射：III期，多中心，随机，双盲，安慰剂对照的24周结果甲氨蝶呤前戈利木单抗作为早期治疗类风湿关节炎的一线治疗的研究。

Effects of Concomitant Methotrexate on Large Joint Replacement in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors: A Multicenter Retrospective Cohort Study in Japan

摘要

著录项

相似文献

相关主题

期刊订阅